Submucosal injection of the oligonucleotide STNM01 is able to induce clinical remission, mucosal healing and histological response in left-sided ulcerative colitis patients with moderate-to-severe disease

Atreya R, Kuehbacher T, Waldner M, Hirschmann S, Drvarov O, Abu Hashem R, Maaser C, Kucharzik T, Dinter J, Schramm C, Mertens J, Holler B, Moessner J, Suzuki K, Yokoyama J, Terai S, Yoneyama H, Asakura H, Hibi T, Neurath M (2017)

Publication Type: Conference contribution

Publication year: 2017

Journal

Journal of Crohns & Colitis Elsevier

Book Volume: 11

Pages Range: S69-S69

Authors with CRIS profile

Raja Atreya Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen Maximilian Waldner Lehrstuhl für Innere Medizin I (Medizin 1) Markus Neurath Lehrstuhl für Innere Medizin I (Medizin 1)

Involved external institutions

Asklepios Kliniken DE Germany (DE) Niigata University / 新潟大学 JP Japan (JP) Universitätsklinikum Köln DE Germany (DE) Universitätsklinikum Leipzig DE Germany (DE) Stelic Institute & Co., Inc. JP Japan (JP) Kitasato University / 北里大学 (Kitasato Daigaku) JP Japan (JP) Städtisches Klinikum Lüneburg DE Germany (DE)

How to cite

APA:

Atreya, R., Kuehbacher, T., Waldner, M., Hirschmann, S., Drvarov, O., Abu Hashem, R.,... Neurath, M. (2017). Submucosal injection of the oligonucleotide STNM01 is able to induce clinical remission, mucosal healing and histological response in left-sided ulcerative colitis patients with moderate-to-severe disease. (pp. S69-S69).

MLA:

Atreya, Raja, et al. "Submucosal injection of the oligonucleotide STNM01 is able to induce clinical remission, mucosal healing and histological response in left-sided ulcerative colitis patients with moderate-to-severe disease." 2017. S69-S69.

BibTeX: Download